Current role
Veer Bhavnagri
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Veer Bhavnagri
The proxy statement of Allogene Therapeutics, Inc. reports total compensation of $4,066,186 for Veer Bhavnagri in fiscal 2022, including a base salary of $480,000. Disclosed compensation is on record for 2 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Allogene Therapeutics, Inc. (ALLO)
Proxy statement
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Allogene Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Zachary Roberts, M.D., Ph.D. CEO, Board Member
- Geoffrey Parker CFO
- Tim Moore CTO
- Timothy Moore CTO
- Annie Yoshiyama Chief Accounting Officer
- Elizabeth Barrett Board Member
- Stephen Mayo, Ph.D. Board Member
- Vicki Sato, Ph.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Allogene Therapeutics, Inc. (ALLO) | — | $480,000 | $4,066,186 |
| 2020 | Allogene Therapeutics, Inc. (ALLO) | — | $425,000 | $2,396,328 |
Recent activity
No call appearances or filed executive changes recorded yet.